$53.6 Million is the total value of Arboretum Ventures, Inc.'s 3 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EQRX INC | $34,281,633 | -50.3% | 13,935,623 | 0.0% | 63.96% | -8.1% | ||
| PEAR THERAPEUTICS INC | $12,813,679 | -42.2% | 10,859,050 | 0.0% | 23.91% | +7.0% | ||
| INGN | INOGEN INC | $6,504,300 | -18.8% | 330,000 | 0.0% | 12.14% | +50.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-01-25
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| EQRX INC | 5 | Q4 2022 | 72.6% |
| PEAR THERAPEUTICS INC | 5 | Q4 2022 | 44.6% |
| INOGEN INC | 5 | Q4 2022 | 12.1% |
View Arboretum Ventures, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-01-25 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-07-22 |
| 13F-HR | 2022-05-11 |
| 13F-HR | 2022-02-09 |
View Arboretum Ventures, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.